Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Manual for 10 Scrumptious Specialty Mixed drinks- 21 Incredibly Entertaining Contemplations To Observe Consistently
- What to know about the "wild, wild West" of viral peptide claims
- Cells have more mini ‘organs’ than researchers thought − unbound by membranes, these rogue organelles challenge biology’s fundamentals
- See the metal guts of a satellite in this wild X-ray view | Space photo of the day for Dec. 4, 2025
- Report: Russian military pressuring students to work as drone pilots
- Passenger Missing After Going Overboard Disney Cruise Ship
- What's your biological age? Experts explain the benefits and risks of at-home tests
- I traveled to 13 countries in 2025. This small island nation surprised me the most.
